Literature DB >> 21697319

Prosthetic joint infection caused by Mycobacterium alvei in an elderly patient.

Chen-Hsiang Lee1, Huey-Ling You, Jun-Wen Wang, Ya-Fen Tang, Jien-Wei Liu.   

Abstract

We report the first case of prosthetic joint infection caused by Mycobacterium alvei, which was identified by PCR-restriction fragment length polymorphism and verified by analysis of nucleotide sequences of its amplified 16S ribosomal DNA. The pathogen was susceptible to linezolid, amikacin, ciprofloxacin, tigecycline, and trimethoprim-sulfamethoxazole. The clinical implications are discussed.

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21697319      PMCID： PMC3147770          DOI： 10.1128/JCM.00603-11

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  15 in total

Review 1.  Prosthetic joint infections.

Authors:  Irene G Sia; Elie F Berbari; Adolf W Karchmer
Journal:  Infect Dis Clin North Am       Date:  2005-12       Impact factor: 5.982

2.  16S ribosomal DNA amplification for phylogenetic study.

Authors:  W G Weisburg; S M Barns; D A Pelletier; D J Lane
Journal:  J Bacteriol       Date:  1991-01       Impact factor: 3.490

3.  Infection of synovial tissues by mycobacteria other than Mycobacterium tuberculosis.

Authors:  P J Kelly; A G Karlson; L A Weed; P R Lipscomb
Journal:  J Bone Joint Surg Am       Date:  1967-12       Impact factor: 5.284

4.  Activities of linezolid against rapidly growing mycobacteria.

Authors:  R J Wallace; B A Brown-Elliott; S C Ward; C J Crist; L B Mann; R W Wilson
Journal:  Antimicrob Agents Chemother       Date:  2001-03       Impact factor: 5.191

5.  Species-specific identification of Mycobacterium leprae by PCR-restriction fragment length polymorphism analysis of the hsp65 gene.

Authors:  N Rastogi; K S Goh; M Berchel
Journal:  J Clin Microbiol       Date:  1999-06       Impact factor: 5.948

6.  Comparison of the in vitro activity of the glycylcycline tigecycline (formerly GAR-936) with those of tetracycline, minocycline, and doxycycline against isolates of nontuberculous mycobacteria.

Authors:  Richard J Wallace; Barbara A Brown-Elliott; Christopher J Crist; Linda Mann; Rebecca W Wilson
Journal:  Antimicrob Agents Chemother       Date:  2002-10       Impact factor: 5.191

7.  The clinicopathological spectrum of non-tuberculous mycobacterial osteoarticular infections.

Authors:  A M Marchevsky; B Damsker; S Green; S Tepper
Journal:  J Bone Joint Surg Am       Date:  1985-07       Impact factor: 5.284

8.  Prosthetic joint infections secondary to rapidly growing Mycobacterium fortuitum.

Authors:  R C Herold; P A Lotke; R R MacGregor
Journal:  Clin Orthop Relat Res       Date:  1987-03       Impact factor: 4.176

9.  Mycobacterium alvei sp. nov.

Authors:  V Ausina; M Luquin; M García Barceló; M A Lanéelle; V Lévy-Frébault; F Belda; G Prats
Journal:  Int J Syst Bacteriol       Date:  1992-10

10.  In vitro activities of tigecycline and 10 other antimicrobials against nonpigmented rapidly growing mycobacteria.

Authors:  R Fernández-Roblas; N Z Martín-de-Hijas; A I Fernández-Martínez; D García-Almeida; I Gadea; J Esteban
Journal:  Antimicrob Agents Chemother       Date:  2008-08-25       Impact factor: 5.191
View more
  3 in total

Review 1.  Prosthetic joint infections in the elderly.

Authors:  G De Angelis; N T Mutters; L Minkley; F Holderried; E Tacconelli
Journal:  Infection       Date:  2015-06-22       Impact factor: 3.553

2.  Clinical experience in 52 patients with tigecycline-containing regimens for salvage treatment of Mycobacterium abscessus and Mycobacterium chelonae infections.

Authors:  Richard J Wallace; Gary Dukart; Barbara A Brown-Elliott; David E Griffith; Ernesto G Scerpella; Bonnie Marshall
Journal:  J Antimicrob Chemother       Date:  2014-03-14       Impact factor: 5.790

3.  Gene Sequencing and Phylogenetic Analysis: Powerful Tools for an Improved Diagnosis of Fish Mycobacteriosis Caused by Mycobacterium fortuitum Group Members.

Authors:  Davide Mugetti; Mattia Tomasoni; Paolo Pastorino; Giuseppe Esposito; Vasco Menconi; Alessandro Dondo; Marino Prearo
Journal:  Microorganisms       Date:  2021-04-10
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.